Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE 00:00 | 01 Jul | 950.10 |
34.90 (3.81%) |
OPEN
915.00 |
HIGH
955.75 |
LOW
914.35 |
| NSE 15:59 | 01 Jul | 949.30 |
32.10 (3.50%) |
OPEN
911.20 |
HIGH
956.05 |
LOW
911.20 |
| OPEN | 915.00 |
| PREVIOUS CLOSE | 915.20 |
| VOLUME | 29812 |
| 52-Week high | 1083.15 |
| 52-Week low | 850.00 |
| P/E | 25.92 |
| Mkt Cap.(Rs cr) | 76,664 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Cipla Ltd. (CIPLA) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 522.55 | 8.75 | 1.70 | 3112.91 |
| Cipla | 950.10 | 34.90 | 3.81 | 2468.28 |
| Dr Reddy's Labs | 4384.35 | -15.55 | -0.35 | 2186.40 |
| Sun Pharma.Inds. | 826.70 | -4.10 | -0.49 | 2139.70 |
| Divi's Lab. | 3634.80 | 3.80 | 0.10 | 1954.72 |
| Glaxosmi. Pharma | 1503.35 | 3.65 | 0.24 | 1690.53 |
| Alkem Lab | 3020.25 | 19.20 | 0.64 | 1685.08 |
| Glenmark Pharma. | 394.00 | 7.00 | 1.81 | 1649.45 |
| Zydus Lifesci. | 362.10 | 5.35 | 1.50 | 1476.20 |
| Lupin | 628.55 | 17.15 | 2.81 | 1258.62 |
| Alembic Pharma | 729.35 | -1.60 | -0.22 | 1175.39 |
| Ipca Labs. | 912.90 | 20.95 | 2.35 | 1140.77 |
| Torrent Pharma. | 2915.00 | 55.60 | 1.94 | 1137.85 |
| Gland Pharma | 2655.90 | -45.95 | -1.70 | 997.01 |
| Sanofi India | 6367.75 | -68.65 | -1.07 | 944.40 |
| Laurus Labs | 466.25 | 1.75 | 0.38 | 750.09 |
| Abbott India | 19081.95 | 294.60 | 1.57 | 690.69 |
| Ajanta Pharma | 1264.65 | 29.85 | 2.42 | 675.64 |
| Wockhardt | 207.70 | -0.80 | -0.38 | 593.29 |
| Granules India | 278.50 | 5.70 | 2.09 | 552.78 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
